Related Experiment Videos
Dexamethasone induces human spinal ligament derived cells toward osteogenic differentiation
Hidenori Murata1, Hiroshi Tanaka, Toshihiko Taguchi
1Department of Orthopedic Surgery, Yamaguchi University School of Medicine, 1-1-1 Minamikogushi, Yamaguchi 755-8505, Japan.
Journal of Cellular Biochemistry
|June 24, 2004
Summary
Dexamethasone treatment induced osteoblastic differentiation in human spinal ligament cells, promoting bone formation markers and extracellular matrix mineralization. This suggests a role for dexamethasone in spinal ligament ossification.
Area of Science:
- Orthopedics
- Cell Biology
- Biochemistry
Background:
- Ossification of spinal ligament involves heterotopic bone formation in spinal ligaments.
- The underlying mechanism may involve osteogenic differentiation of spinal ligament cells.
Purpose of the Study:
- To investigate the osteogenic potential of human spinal ligament cells in vitro.
- To determine the effect of dexamethasone on spinal ligament cell differentiation.
Main Methods:
- Human spinal ligament cells were treated with dexamethasone in vitro.
- Assessed cell morphology, growth, alkaline phosphatase activity, and gene expression (pro-alpha1(I) collagen, alkaline phosphatase, osteocalcin).
- Evaluated extracellular matrix mineralization.
Main Results:
- Dexamethasone altered cell morphology and suppressed growth at high concentrations.
- Increased alkaline phosphatase activity and expression of pro-alpha1(I) collagen and osteocalcin mRNA.
- Induced extracellular matrix mineralization, enhanced by 1,25-dihydroxyvitamin D(3).
Conclusions:
- Dexamethasone promotes osteoblastic differentiation of human spinal ligament cells.
- These findings suggest a potential role for dexamethasone in the pathogenesis of spinal ligament ossification.